Gw Pharmaceuticals reported $129.14M in Stock for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
ALKERMES ALKS:US $ 138.7M 2.62M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bluebird Bio BLUE:US $ 0.77M 12.74M
Clovis Oncology CLVS:US $ 17.28M 7.72M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
YTE INCY:US $ 21.3M 4.63M
Zogenix ZGNX:US $ 3.5M 0.58M